A Phase I Trial to Evaluate Safety and Tolerance of Intravenous 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Adolescent and Young Adults (AYA) Subjects With Cancers
Latest Information Update: 17 Jan 2022
At a glance
- Drugs Mipicoledine (Primary)
- Indications Advanced breast cancer; Astrocytoma; Cancer; Malignant melanoma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Expanded access
- Sponsors Dekk-Tec
- 28 Apr 2020 Status changed from active, no longer recruiting to completed.
- 28 Apr 2020 Results presented at the 111th Annual Meeting of the American Association for Cancer Research - I
- 05 Sep 2018 Status changed from recruiting to active, no longer recruiting.